Asahi Kasei Pharma Develops Osteoporosis Patch Drug With Global Market In Mind
This article was originally published in PharmAsia News
Executive Summary
Asahi Kasei Pharma Co. Ltd plans to develop and market the first transdermal peptide agent for osteoporosis in Asia.